NCT00047515View on ClinicalTrials.gov

Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2001

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Alcon Investigational Agent

Trial Locations (1)

76134

Clinical Trial Sites, Multiple Locations Throughout the United States

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY